Characteristics of serious complicated gastroduodenal ulcers in Japan

Hepato-Gastroenterology

Volumn 59, Issue 113, 2012, Pages 147-154

  Ishikawa, Shigenao ^a   Inaba, Tomoki ^a   Mizuno, Motowo ^b   Miyake, Yasuhiro ^c   Okada, Hiroyuki ^c   Ishikawa, Hisashi ^a   Hori, Keisuke ^a   Wato, Masaki ^a   Kawai, Kozo ^a   Yamamoto, Kazuhide ^c  

^a KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b HIROSHIMA CITY HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bleeding ulcer; Complication; Gastroduodenal ulcer; Low dose aspirin; Non steroidal anti inflammatory drugs (NSAID); Perforated ulcer

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DUODENAL ULCER BLEEDING; FEMALE; GASTRODUODENAL ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONHUMAN; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; ULCER PERFORATION;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84863418583     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge09689     Document Type: Article

References (37)

1. Antithrombotic Trialists Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
2. Patrono C, García Rodríguez LA, Landolfi R, et al.: Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353:2373-2383. (Pubitemid 41713749)
3. Nakayama M, Iwakiri R, Hara M, et al.: Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J Gastroenterol 2009; 44(9):912-8.
4. Van Leerdam ME, Vreeburg EM, Rauws EA, et al.: Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98:1494-1499. (Pubitemid 36875338)
5. Tsokos M, Schmoldt A: Contribution of nonsteroidal anti-inflammatory drugs to deaths associated with peptic ulcer disease: a prospective toxicological analysis of autopsy blood samples. Arch Pathol Lab Med 2001; 125:1572-1574. (Pubitemid 33152052)
6. Lassen A, Hallas J, Schaffalitzky de Muckadell OB: Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006; 101:945-953. (Pubitemid 43725306)
7. Huang JQ, Sridhar S, Hunt RH: Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359:14-22. (Pubitemid 34119190)
8. Papatheodoridis GV, Sougioultzis S, Archimandritis AJ: Effects of Helicobacter pylori and non-steroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 2006; 4:130-142. (Pubitemid 43199681)
9. Sakamoto C, Sugano K, Ota S, et al.: Case-control study on the association of upper gastrointestinal bleeding and non-steroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006; 62:765-772. (Pubitemid 44289508)
10. Maeda S, Ogura K, Yoshida H, et al.: Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998; 42:338-343. (Pubitemid 28197021)
11. Shiotani A, Sakakibara T, Yamanaka Y, et al.: The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy. J Gastroenterol 2009; 44:717-725.
12. Kawai T, Kawakami K, Kudo T, et al.: A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Intern Med 2002; 41:780-783. (Pubitemid 35314775)
13. Charlson ME, Pompei P, Ales KL, et al.: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383. (Pubitemid 17055592)
14. Cheatum DE, Arvanitakis C, Gumpel M, et al.: An endoscopic study of gastroduodenal lesions induced by nonsteroidal antiinflammatory drugs. Clin Ther 1999;21:992-1003. (Pubitemid 29326159)
15. Yeomans ND, Lanas AI, Talley NJ, et al.: Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005; 22:795-801. (Pubitemid 41564359)
16. Goldstein JL: Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis? Eur J Gastroenterol Hepatol 2000; 12:S11-15.
17. Taha AS, Angerson WJ, Prasad R, et al.: Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008; 28:878-885.
18. Cohen M, Sapoznikov B, Niv Y: Primary and secondary nonvariceal upper gastrointestinal bleeding. J Clin Gastroenterol 2007; 41:810-813. (Pubitemid 47442705)
19. Taha AS, Angerson WJ, Knill-Jones RP, et al.: Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005; 22:285-289. (Pubitemid 41207457)
20. Topol EJ, Falk GW: A coxib a day won't keep the doctor away. Lancet 2004; 364:639-640. (Pubitemid 39140604)
21. Hippisley-Cox J, Coupland C: Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005; 330:1366.
22. Laine L: Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk? Aliment Pharmacol Ther 2006; 24:897-908.
23. Campbell CL, Smyth S, Montalescot G, et al.: Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA 2007; 297:2018-2024. (Pubitemid 46740354)
24. Lanas A, Bajador E, Serrano P, et al.: Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000; 343:834-839.
25. Lanas A, García-Rodríguez LA, Arroyo MT, et al.: Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006; 55:1731-1738. (Pubitemid 44893570)
26. Nardulli G, Lanas A: Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants. Gastroenterol Hepatol 2009; 32:36-43.
27. García Rodríguez LA, Barreales Tolosa L: Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007; 132:498-506. (Pubitemid 46274667)
28. Thomsen RW, Riis A, Christensen S, et al.: Outcome of peptic ulcer bleeding among users of traditional non-steroidal antiinflammatory drugs and selective cyclo-oxygenase-2 inhibitors. Aliment Pharmacol Ther 2006; 24:1431-1438. (Pubitemid 44657119)
29. Goldstein JL, Lowry SC, Lanza FL, et al.: The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor. Aliment Pharmacol Ther 2006; 23:1489-1498.
30. Chan FK, Chung SC, Suen BY, et al.: Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344:967-973. (Pubitemid 32240315)
31. Lanas A, Scheiman J: Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 2007; 23:163-173. (Pubitemid 46201599)
32. Lai KC, Lam SK, Chu KM, et al.: Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346:2033-2038. (Pubitemid 34680594)
33. Serrano P, Lanas A, Arroyo MT, et al.: Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002; 16:1945-1953.
34. Lanas A, García-Rodríguez LA, Arroyo MT, et al.: Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, anti-platelet agents and anticoagulants. Am J Gastroenterol 2007; 102:507-515. (Pubitemid 46328156)
35. Scheiman JM: Strategies to reduce the GI risks of anti-platelet therapy. Rev Cardiovasc Med 2005; 6:S23-31.
36. Nakashima S, Arai S, Mizuno Y, et al.: A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005; 21:60-66. (Pubitemid 40806583)
37. Miyake K, Ueki N, Suzuki K, et al.: Preventive therapy for nonsteroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. Aliment Pharmacol Ther 2005;21:67-72 (Pubitemid 40806584)